GGrantIndex
Sort

326,823 grants matching clinical trial

CLINICAL AND TRANSLATIONAL SCIENCE AWARD

$2,587,375
Robert Stanley Sherwin · Yale University · UL1 · FY2010 · RR

Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)

$2,587,255
David A Smelson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · MH

Translational Center of Tissue Chip Technologies for quantitative characterization of Microphysiological Systems

$2,587,153
Murat Cirit · Massachusetts Institute Of Technology · U24 · FY2017 · TR

HSV-1 Amplicon Vectors for HIV Vaccine Delivery

$2,586,750
Michael C Keefer · University Of Rochester · P01 · FY2006 · AI

SPORE IN LUNG CANCER

$2,586,702
University Of Colorado Denver · P50 · FY2001 · CA

PACT

$2,586,667
Leslie Silberstein · Boston Children'S Hospital · N01 · FY2014 · HL

Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men

$2,586,659
Anne Frey Luetkemeyer · University Of California, San Francisco · R01 · FY2022 · AI

Cancer Therapy Evaluation Program's Informatics and Computer Support

$2,586,544
Sudhir Raju · Ctis, Inc. · N02 · FY2009 · CA

Nanosystems Biology Cancer Center 2

$2,586,441
James R. Heath · California Institute Of Technology · U54 · FY2010 · CA

Molecular Transducers of Physical Activity Clinical Centers (U01) - Pittsburgh Adult Clinical Center

$2,586,205
John M Jakicic · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · AR

UCLA Los Angeles Brazil AIDS Consortium

$2,586,074
Yvonne J Bryson · University Of California Los Angeles · U01 · FY2010 · AI

The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center

$2,585,894
Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA

Targeted Bone Regeneration via Activation of Resident Stem Cells

$2,585,805
Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR

Novel Therapies for Muco-Obstructive Lung Diseases

$2,585,676
Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2015 · HL

Co-occurring ADHD in young children with ASD: Precursors, detection, neural signatures, and early treatment

$2,585,606
Geraldine Dawson · Duke University · P50 · FY2018 · HD

DF/HCC Prostate SPORE

$2,585,567
Himisha Beltran · Dana-Farber Cancer Inst · P50 · FY2023 · CA

Oral Ciclopirox Treatment for Congenital Erythropoietic Porphyria.

$2,585,421
Robert J Desnick · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · FD

Pharmacogenomics and Risk of Cardiovascular Disease

$2,584,979
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U19 · FY2012 · HL

Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?

$2,584,873
Kyle Matthew Kampman · University Of Pennsylvania · UH3 · FY2025 · DA

DANA-FARBER/HARVARD SPORE IN BREAST CANCER

$2,584,815
Dana-Farber Cancer Institute · P50 · FY2000 · CA

PACIFIC NORTHWEST PROSTATE CANCER SPORE

$2,584,662
Fred Hutchinson Cancer Research Center · P50 · FY2005 · CA

KENTUCKY CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE

$2,583,778
Philip A Kern · University Of Kentucky · UL1 · FY2011 · RR

Dental PBRN Network Chair

$2,583,157
Gregg H Gilbert · University Of Alabama At Birmingham · U01 · FY2008 · DE

Mechanisms and Therapy of Chronic Graft-vs.-Host Disease

$2,583,098
Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2023 · HL

Specialized Programs of Translational Research in Acute Stroke at the Partners

$2,582,989
Karen L. Furie · Massachusetts General Hospital · P50 · FY2010 · NS